Kedrion is a biopharmaceutical company specializing in the development, manufacturing, and distribution of plasma-derived products. It plays a key leadership role in the plasma-derived therapies sector in Italy, Europe, and worldwide.
Kedrion's competitive edge lies in its commitment to product quality, continuous research and development, strong corporate leadership, and successful positioning in both domestic and international markets.
The company’s core plasma-derived products include immunoglobulins, coagulation factors (Factor VIII and Factor IX), coagulation inhibitors (Antithrombin III), and human serum albumin infusions. Kedrion is also actively involved in plasma collection, operating across Italy (with approximately 360 blood transfusion centers) as well as internationally, including in the United States, Germany, and Austria.
Immune System Therapeutic Products
KEDRION
Immunoglobulin can help with immune system-related diseases.
For patients with no immune response, insufficient immune response (primary or secondary immunodeficiency), or incomplete immune response (e.g., autoimmune diseases), passive immunoglobulin therapy is required for prevention or treatment.
-
Standard immunoglobulins
-
Hyperimmunoglobulins
Critical Care Products
KRDRION
Plasma products are used for emergency care, resuscitation, critical care, and surgical patients.
-
Human albumin
-
Antithrombin
Coagulation Factor Products
KEDRION
Coagulation factors are used for the prevention and treatment of congenital and acquired bleeding disorders or excessive bleeding conditions.
-
Factor VIII concentrate
-
Factor IX concentrate
-
Prothrombin complex concentrate (PCC)
The 8 Key Steps of KEDRION's Quality Management System
-
Qualified Blood Donor Control
-
Each Blood Plasma Donation Testing
-
Traceability Mechanism
-
NAT Testing with High Detection Rate
-
Manufactured in an Italy PIC/S GMP Certified Pharmaceutical Plant
-
Validated Virus Inactivation/Removal Steps
-
Certified by National Regulatory Authorities
-
Strict Implementation of Drug Surveillance and Adverse Reaction Monitoring
Kedrion's quality management system is a key factor in the company's competitive advantage. Continuous quality improvement, staff training, and process monitoring are integrated into the quality management system.
To ensure the quality, efficacy, and safety of the products manufactured, Kedrion has developed a unique multi-step processing procedure called the Kedrion Quality Plan (KQP), which continuously monitors every step of the production process. Regular inspections by health authorities in Italy and abroad confirm compliance with GMP (Good Manufacturing Practices) standards.
GXP represents a series of international scientific quality standards. Kedrion adheres to GLP (Good Laboratory Practices), GCP (Good Clinical Practices), GMP (Good Manufacturing Practices), and GDP (Good Distribution Practices). Our goal is to obtain written proof of consistent production processes and compliance with product specifications and quality requirements. Kedrion has also achieved the SA 8000 standard (Social Accountability), UNI EN ISO 9001:2000 (Quality Management Systems), UNI EN ISO 14001 (Environmental Management Systems), EMAS registration (Environmental Management), and BS OHSAS 18001 (Occupational Health and Safety).
Kedrion has also been awarded the Excellence, Assurance, and Leadership certification by the Plasma Protein Therapeutics Association (PPTA).
Kedrion currently produces and sells the following products
